<
>
Life saving sepsis therapy, Prelaunch campaign
Eisai
About 750,000 people develop sepsis in the U.S. every year, and a third of them die from the condition. This prelaunch campaign was to set the stage for the first new therapy in the category.
Easai Eritoran
Sepsis prelaunch